Lilly Deepens ALS Pipeline With $415M Alchemab Lic...
Category : Licensing/Collaboration Deal 8 May 2025The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral...
The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral...
Addex Therapeutics has signed an option and collaboration agreement with Sinntaxis AB. Recovery a...
Biohaven will use the money to bankroll commercial preparations for the spinocerebellar ataxia drug...
Orion Corporation (Orion), is a globally operating Nordic pharmaceutical company, and Criceto IKM B....
Gene Solutions has announced a strategic collaboration with Element Biosciences. The partne...